EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension

Nicholas D Cober iD, Emma McCourt, Rafael Soares Godoy, Yupu Deng, Ken Schlosser, Elmira Safaie Qamsari, Jalil Azami, Elham Salehisiavashani, David P Cook iD, Sarah-Eve Lemay, Timothy Klouda, Ke Yuan und 2 weitere

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Nicholas D Cober und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sinclair Centre for Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. Hauptthemen laut MEDLINE: Vascular Remodeling, Pulmonary Artery, Pulmonary Arterial Hypertension, Endothelial Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, Canadian Vascular Network, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Pulmonary arterial hypertension (PAH) is a lethal pulmonary vascular disease characterized by arteriolar pruning and occlusive vascular remodelling leading to increased pulmonary vascular resistance and eventually right heart failure. While endothelial cell (EC) injury and apoptosis are known triggers for this disease, the mechanisms by which they lead to complex arterial remodelling remain obscure. We employed multiplexed single-cell RNA sequencing at multiple timepoints during the onset and progression of disease in a model of severe PAH to identify mechanisms involved in the development of occlusive arterial lesions. Methods and results Single-cell transcriptional analysis resolved 44 global lung cell populations, with widespread early transcriptomic changes at 1 week affecting endothelial, stromal, and immune cell populations. In particular, two EC clusters were greatly expanded during PAH development and were identified as being disease specific: a relatively de-differentiated (dD) EC population that was enriched for Cd74 expression while exhibiting a loss of endothelial identity; and an activated arterial EC (aAEC) population that uniquely exhibited persistent differential gene expression throughout PAH development consistent with a growth regulated state. dDECs were primed to undergo endothelial–mesenchymal transition as evidenced by reduced activity of master EC transcription factors, Erg and Fli1, and further supported by RNA velocity analysis showing vectors leading to fibroblast clusters. Of note, aAECs exhibited high expression of Tm4sf1, a gene implicated in cancer cell growth, that was also expressed by a smooth muscle (SM)-like pericyte cluster, and were highly localized to regions of arterial remodelling in both the rat model and PAH patients, contributing to intimal occlusive lesions and SM-like pericytes forming bands of medial muscularization.

Conclusion

Together these findings implicate disease-specific vascular cells in PAH progression and suggest that TM4SF1 may be a novel therapeutic target for arterial remodelling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular RemodelingPulmonary ArteryPulmonary Arterial HypertensionEndothelial CellsTranscriptomeArterial PressureAnimalsDisease Models, AnimalSingle-Cell AnalysisMaleCells, CulturedHumansPhenotypeRNA-SeqTime FactorsRats, Sprague-Dawley

Stichwörter der Autor:innen

Endothelial cellsPericytesPulmonary arterial hypertensionVascular remodelling

Autor:innen und Institutionen

  • Sinclair Centre for Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, 501 Smyth Road, Box/C.P. 511, Ottawa, ON, K1H 8L6, Canada.
  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Research Center Laval University, Quebec City, QC, Canada.
  • Division of Pulmonary Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Nicholas D Cober, David P Cook, Duncan J Stewart

Förderung

  • CIHR
  • Canadian Vascular Network
  • Canadian Institutes of Health Research

Zitieren

APA

Cober, N. D., McCourt, E., Godoy, R. S., Deng, Y., Schlosser, K., Qamsari, E. S., Azami, J., Salehisiavashani, E., Cook, D. P., Lemay, S. E., Klouda, T., Yuan, K., Bonnet, S., & Stewart, D. J. (2025). Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf146

Vancouver

Cober ND, McCourt E, Godoy RS, Deng Y, Schlosser K, Qamsari ES, et al. Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf146

BibTeX
@article{Cober2025,
  author = {Cober, Nicholas D and McCourt, Emma and Godoy, Rafael Soares and Deng, Yupu and Schlosser, Ken and Qamsari, Elmira Safaie and Azami, Jalil and Salehisiavashani, Elham and Cook, David P and Lemay, Sarah-Eve and Klouda, Timothy and Yuan, Ke and Bonnet, Sébastien and Stewart, Duncan J},
  title = {Mapping disease-specific vascular cell populations responsible for obliterative arterial remodelling during the development of pulmonary arterial hypertension},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf146}
}
Kostenlos starten →